The Global Diabetes Devices Market is anticipated to exhibit an impressive CAGR of 5.5% on account of rising prevalence of diabetes. Key insights into this fast growing market, valued at US$ 32,441.3 mn in 2018, have been shared by Fortune Business Insights in its report, titled “Diabetes Devices Market Size, Share and Global Trend By Product (Monitoring Devices, Treatment Devices), By Distribution Channel (Institutional Sales, Retail Sales) and Geography Forecast till 2026”. The report brings out the key aspects that will influence the market in the forecast period. Diabetes is a metabolic disease in which the body is unable to process glucose, leading to elevated levels of blood sugar. This happens as the body does not make enough insulin (a hormone made by the pancreas), which helps the glucose enter the cells and supply the body with energy to function. Diabetes devices such as insulin pumps and continuous glucose monitors are used by medical professionals and patients to regulate and monitor blood glucose levels.

Browse Complete Report Details@

https://www.fortunebusinessinsights.com/industry-reports/diabetes-devices-market-100803

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Diabetes Devices market. Some of the companies operating the global Diabetes Devices market are;

• Hoffmann-La Roche Ltd.
• Medtronic
• Tandem Diabetes Care, Inc.
• BD
• Eli Lilly
• Company
• Sanofi

key industry developments

• In September 2018, DiaMonTech GmbH, in, launched a shoebox-sized device that can diagnose the blood glucose levels by using an infrared light beam through the skin.
• In February 2019, Tandem Diabetes Care, Inc., received FDA approval for the marketing of the first insulin pump with interoperable technology for children and adults with diabetes. t: Slim X2 insulin pump is the first device to be classified under a new de novo premarket review pathway.
• In July 2019, F. Hoffmann-La Roche Ltd. received safety approval for the launch of the Accu-Chek Solo insulin patch pump and wireless touchscreen handheld in Europe.

Growing Competition to Spruce Up the Market

The fast-growing global diabetes devices market being augmented by innovation of key players. Increased investment in research and development by pharmaceutical companies is leading to development of innovative products such as non-invasive reusable devices. For example, in June 2019, Nemaura Medical commercially launched its non-invasive and needle-free continuous glucose monitor, SugarBEAT, in Germany and Europe. The device is also the world’s first of its kind. Among the major participants, Hoffman-La Roche has emerged as a market leader owing to its diverse product portfolio of diabetes devices and a well-established global distribution network.

The rising demand from musculoskeletal application segment is prognosticated to help the global magnetic resonance imaging equipment market rise at a positive pace, finds Fortune Business Insights in their new study. The study is titled, “Magnetic Resonance Imaging Equipment Market: Global Market Analysis, Insights and Forecasts, 2018 – 2025.” According to the study, the global magnetic resonance imaging equipment market, which stood at US$ 7,165.6 Mn in 2017, will reach US$ 11,725.9 Mn by the end of 2025. If these figures prove true, the global magnetic resonance imaging equipment market will rise at a CAGR of 6.4% between 2018 and 2025.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/magnetic-resonance-imaging-mri-systems-market-100087

Key Players Operating in The MRI Equipment Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• GE Healthcare
• Siemens Healthcare
• Koninklijke Philips N.V.
• Canon Inc.
• Hitachi, Ltd.
• Esaote SpA
• Shenzhen Anke High-tech Co., Ltd.
• Time Medical Holding
• SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
• Fonar Corporation

The musculoskeletal segment is anticipated to rise at a faster rate among other categories based on application. This is due to the recently proven clinical efficacy of MRI systems in detailed bone imaging cases. Again, the neurology segment, out of various applications will register a higher CAGR because of the expansion of neuroscience in developed nations and its application in medical therapies and testing devices. On the other hand, the hospital segment is likely to generate more revenue over the next few years, because of the significant rise in funding by governments

Increasing Emphasis of Early Diagnosis to Boost MRI Equipment Market in Latin America

The increasing adoption of MRI systems for detection of severe internal injuries is propelling the MRI equipment market in Asia Pacific. This regional market also exhibits growth at a relatively higher pace. Besides, the increasing incidence of neurological and musculoskeletal disorders and rising number of patient pool will also bode well for the market. Government initiatives for installing new MRI machines in developing economies is likely to boost the market in Asia Pacific.

The adoption of new MRI techniques and the presence of majority of market players in North America will help the market to emerge at the fore. Meanwhile, the market in Latin America is likely to witness lucrative growth opportunities because of the increased adoption of MRI systems in the region. This, coupled with the rising emphasis of early diagnosis will help the market in Latin America contribute a significant share in overall market revenue.

Strategic Collaborations among Key Players to Give Tailwinds to Growth

The global genomics market size is projected to reach USD 62614.6 million by 2026. Genomics has successfully transformed the way of preventing, managing and treating diseases. Researchers at the University of Paris-Saclay believe that we have entered into the third revolution of sequencing technology in the world of genetics. Moreover, several companies are planning to build third-generation sequencing technology to stay abreast of new trends. As per a recent report published by Fortune Business Insights, titled “Genomics Market Size, Share and Industry Analysis By Type (Products, Services), Technology (Polymerase Chain Reaction, Next-generation Sequencing, Microarray, Sanger Sequencing), Application (Diagnostics, Research), End-User (Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROs)) & Regional Forecast, 2019 – 2026,” the market value stood at USD 15888.8 million in 2018 and is anticipated to exhibit an exponential CAGR of 18.7% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941

Some of the other leading players operating in the global market are:

• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies
• Danaher
• QIAGEN
• BGI
• IntegraGen

The genomics market report outlines the present and future scenario of the market by offering key insights into the trends and drivers stimulating growth. Furthermore, it highlights detailed information on several aspects of the market which include opportunities, challenges, and threats. The report throws lights on the competitive landscape by covering key developments of some of the leading players. It also highlights strategies adopted by players, which in turn, can help stakeholders to make business decisions. Further to this, it also showcases information on all the major segments and their respective market share.

Advancements in Bioinformatics to Boost the Market in North America

Among regions, North America is anticipated to emerge dominant in the global genomics market throughout the forecast years. In 2018, the market value stood at USD 6959.3 million. This is ascribable to the rising focus on pharmacogenomics and technological advancements in bioinformatics. This, coupled with increasing adoption of new sequencing technologies, will create growth opportunities for the market in this region. Rising preference for personalized medicines is another factor responsible for the dominance of market in this region.

Detailed Table of Content:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2.Executive Summary

3.Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3 Market Opportunities

3.4 Market Trends

4.Key Insights

4.1GenomicsResearch Spending – For Key Countries, 2018

4.2RegulatoryScenario – For Key Countries

4.3Overview of Genomics Service Provider

4.4New Product Launch

4.5Start-upswith their Funding Overview

4.5Key Industry Developments – Mergers, Acquisitions and Partnerships

The global genomics market size is projected to reach USD 62614.6 million by 2026. Genomics has successfully transformed the way of preventing, managing and treating diseases. Researchers at the University of Paris-Saclay believe that we have entered into the third revolution of sequencing technology in the world of genetics. Moreover, several companies are planning to build third-generation sequencing technology to stay abreast of new trends. As per a recent report published by Fortune Business Insights, titled “Genomics Market Size, Share and Industry Analysis By Type (Products, Services), Technology (Polymerase Chain Reaction, Next-generation Sequencing, Microarray, Sanger Sequencing), Application (Diagnostics, Research), End-User (Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROs)) & Regional Forecast, 2019 – 2026,” the market value stood at USD 15888.8 million in 2018 and is anticipated to exhibit an exponential CAGR of 18.7% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941

Some of the other leading players operating in the global market are:

• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies
• Danaher
• QIAGEN
• BGI
• IntegraGen

The genomics market report outlines the present and future scenario of the market by offering key insights into the trends and drivers stimulating growth. Furthermore, it highlights detailed information on several aspects of the market which include opportunities, challenges, and threats. The report throws lights on the competitive landscape by covering key developments of some of the leading players. It also highlights strategies adopted by players, which in turn, can help stakeholders to make business decisions. Further to this, it also showcases information on all the major segments and their respective market share.

Helix’s New DNA Studio to Aid in Expansion of the Market

Genomics has proved to be successful in the diagnosis of chronic diseases such as cancer. Owing to the increasing prevalence of cancer around the world, the demand for genomics products and services is expected to increase in the forthcoming years. As per the recent genomics market trends, product segment is expected to lead the market in the forecast years. The growth is attributable to the rising use of consumables and increasing number of product launches. For instance, a personal genomics company called Helix announced the launch of a new DNA product studio in October 2018. The aim of this launch is to build and distribute DNA products, thereby benefitting hundreds and thousands of people who want to know how DNA plays a crucial role in wellness and health.

Advancements in Bioinformatics to Boost the Market in North America

Among regions, North America is anticipated to emerge dominant in the global genomics market throughout the forecast years. In 2018, the market value stood at USD 6959.3 million. This is ascribable to the rising focus on pharmacogenomics and technological advancements in bioinformatics. This, coupled with increasing adoption of new sequencing technologies, will create growth opportunities for the market in this region. Rising preference for personalized medicines is another factor responsible for the dominance of market in this region.

The rising prevalence of unwanted pregnancies is boosting the global contraceptive drugs market. In a report, titled “Contraceptive Drugs Market Size, Share and Global Trend By Product Type (Oral, Injectable, Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs) and Geography Forecast till 2025” Fortune Business Insights identifies various factors enabling growth in the market.

According to the report, the global contraceptive drugs market is anticipated to rise at 5.8% CAGR and reach a value of US$ 20,200.5 Mn by 2025 from US$ 13,097.7 Mn in 2017. Remarkably improving access to contraceptive pills around the world is a key factor propelling growth in this market.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-drugs-market-100063

Leading Players operating in the Contraceptive Drugs Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Bayer AG

• Pfizer Inc.
• Janssen Global Services, LLC
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc.
• Mylan N.V.
• Allergan Plc
• Agile Therapeutics

Piramal Enterprises Ltd

Rising Abortion Rates to Create Demand for Contraceptive Drugs

Under the Affordable Care Act (ACA) in the U.S., oral contraceptive pills are given free of cost to women in the U.S. Such regulations favor the growth of the contraceptive drugs market. Increasing government initiatives to reduce infant mortality due to early pregnancies will increase the demand for oral contraceptives. Contraceptive drugs not only help to control unwanted pregnancies but also reduce the number of abortion and complications associated with the procedure worldwide. As per the World Health Organization, there is an estimated 40 to 50 million abortions every year, corresponding to an approximate of 125,000 abortions per day. To avoid unwanted and unplanned pregnancies, an increasing number of women are opting for contraceptive drugs. This will in turn augment growth in the global market.

Contrary to this, the market for contraceptive drugs may face challenges posed by religious, ethical, and social barriers especially in more conservative regions. Social taboos often discourage the use of contraceptive drugs among women, subsequently adversely impacting the overall market.

The rising demand from musculoskeletal application segment is prognosticated to help the global magnetic resonance imaging equipment market rise at a positive pace, finds Fortune Business Insights in their new study. The study is titled, “Magnetic Resonance Imaging Equipment Market: Global Market Analysis, Insights and Forecasts, 2018 – 2025.” According to the study, the global magnetic resonance imaging equipment market, which stood at US$ 7,165.6 Mn in 2017, will reach US$ 11,725.9 Mn by the end of 2025. If these figures prove true, the global magnetic resonance imaging equipment market will rise at a CAGR of 6.4% between 2018 and 2025.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/magnetic-resonance-imaging-mri-systems-market-100087

Key Players Operating in The MRI Equipment Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• GE Healthcare
• Siemens Healthcare
• Koninklijke Philips N.V.
• Canon Inc.
• Hitachi, Ltd.
• Esaote SpA
• Shenzhen Anke High-tech Co., Ltd.
• Time Medical Holding
• SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
• Fonar Corporation

The musculoskeletal segment is anticipated to rise at a faster rate among other categories based on application. This is due to the recently proven clinical efficacy of MRI systems in detailed bone imaging cases. Again, the neurology segment, out of various applications will register a higher CAGR because of the expansion of neuroscience in developed nations and its application in medical therapies and testing devices. On the other hand, the hospital segment is likely to generate more revenue over the next few years, because of the significant rise in funding by governments.

Increasing Emphasis of Early Diagnosis to Boost MRI Equipment Market in Latin America

The increasing adoption of MRI systems for detection of severe internal injuries is propelling the MRI equipment market in Asia Pacific. This regional market also exhibits growth at a relatively higher pace. Besides, the increasing incidence of neurological and musculoskeletal disorders and rising number of patient pool will also bode well for the market. Government initiatives for installing new MRI machines in developing economies is likely to boost the market in Asia Pacific.

The adoption of new MRI techniques and the presence of majority of market players in North America will help the market to emerge at the fore. Meanwhile, the market in Latin America is likely to witness lucrative growth opportunities because of the increased adoption of MRI systems in the region. This, coupled with the rising emphasis of early diagnosis will help the market in Latin America contribute a significant share in overall market revenue.

The Global Telehealth Market is likely to expand considerably with impetus from the ability of telehealth to serve the rural population. According to a report published by Fortune Business Insights, titled “Telehealth: Global Market Analysis, Insights, and Forecast, 2019-2026,” The Global Telehealth Market was valued at US$ 49.8 Bn in 2018. Fortune Business Insights has predicted that the market will reach US$ 266.8 Bn by 2026, thereby exhibiting a CAGR of 23.4%.

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/telehealth-market-101065

Key players leading the global Telehealth Market include

• American Well,
• Teladoc Health,
• Doctor On Demand,
• GlobalMed,
• Dictum Health, Inc., LLC,
• InTouch Technologies, Inc.,
• MDLIVE Inc.,
• Encounter Telehealth,
• HelloMD,

The ability of Telehealth Market to access and manage healthcare services has led to their rising uptake across the world. Telehealth is used to enhance healthcare services as well as increase feasibility within the healthcare services. Recent technological advancements in telehealth services have created huge potential for growth of the global telehealth market for the forthcoming years. The ability of telehealth services and products to reach out to rural areas and people who cannot access healthcare facilities has created a huge demand across the world. Resulting from such exceptional benefits for telehealth products, investors have identified this market as a gem and have identified several growth opportunities for the telehealth market companies around the world. Additionally, applications of telehealth in improving coordination and communication among the healthcare team will contribute to the increasing demand for telehealth products across the world.

Technological Advancements to Fuel Demand for Telehealth Services

The technological advancements in telehealth products and services have fuelled the demand for telehealth services across the world. The advent of user-friendly systems has contributed to a high demand, which in turn has led to an increase in the global telehealth market value in recent years. In 2019, InTouch announced the launch of a fully integrated end-to-end virtual platform aimed at providing enhanced patient care solutions. ‘Solo’ was a flexible platform integrated with services such as enhanced emergency care solutions, direct-to-patient, and direct-to-customer, which in turn will contribute to the growth of the global telehealth market in the coming years.

Company Collaborations Are Proving Chief Growth Drivers

Due to the increasing demand, telehealth market companies are adopting collaborative strategies with the aim of expanding business on a global scale. Furthermore, leading companies in the telehealth industry are focusing on mergers and acquisitions to gain competitive strength. Companies are trying to incorporate modern industrial concepts with a view to gain more end users. Fortune Business Insights expects market collaborations will help companies generate substantial telehealth market revenue. In April 2018, American Well acquired Avizia Limited with the aim of strengthening its position among the companies in the telehealth industry. American Well’s acquisition of Avizia will help the company take a big leap in the telehealth market, owing to the exceptional portfolio of telehealth services bolstered by Avizia. The report includes company mergers, similar to American Well’s latest acquisition and signifies the impact of such M&As on the global telehealth market.

According to the World Bank, approximately 84% populace in Germany depend on Internet and around 75% populace in the U.S. are subscribers of the Internet, which augments the global ePharmacy market growth. Fortune Business Insights states that the global ePharmacy market is projected to reach US$ 177,794.9 Mn by 2026, thereby exhibiting an impressive CAGR of 17.3% during the forecast period (2019-2026). The company further states that the global market was valued at US$ 49,727.7 Mn in 2018. According to a published report by Fortune Business Insights, titled, “ePharmacy: Global Market Analysis, Insights and Forecast, 2019-2026,” the global ePharmacy market will witness notable growth during the forecast period due to the technological advancements based on artificial intelligence.

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/epharmacy-market-100238

Fortune Business Insights has profiled some of the prominent market players operating in the global ePharmacy market. They are as follows:

• DocMorris
• CVS Health Corporation
• Express Script Holding Company
• Walgreen Co.
• Optum Rx, Inc.
• Giant Eagle, Inc.
• Walmart Stores, Inc.
• Rowland Pharmacy
• The Kroger Co.
• Other players

Increasing Adoption of E-commerce Websites to Favor Growth in Asia Pacific

Geographically, the global ePharmacy market is grouped into Asia Pacific, North America, the Middle East and Africa, Europe, and Latin America. Out of these regions, North America is expected to remain in the leading position in the global ePharmacy market during the forecast period. The growth is attributed to the rapid shift of consumers towards online retailers from offline pharmacies. Also, increasing usage of smartphones and high speed of the Internet are expected to aid North America in gaining the highest global ePharmacy market share in the forthcoming years. Furthermore, a rise in geriatric population, increasing online orders, and growing adoption of online platforms will drive the market growth in this region.

Europe and Asia Pacific, on the other hand, are projected to exhibit significantly high CAGR during the forecast period. In Europe, numerous prominent market players have begun offering products at lucrative rates. This will positively impact growth of ePharmacy market in this region. Asia Pacific, on the other hand, has been witnessing higher adoption of e-commerce websites and increasing patient pool. Moreover, the healthcare infrastructure in this region is on the verge of becoming prosperous. All these factors are anticipated to fuel ePharmacy market growth in Asia Pacific in the coming years.

Some major points from Table of Content:

1. Introduction
   • Research Scope
   • Market Segmentation
   • Research Methodology
   • Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   • Market Drivers
   • Market Restraints
   • Market Opportunities
4. Key Insights
   • Key Start-ups and Funding Overview
   • Key Industry Developments – Mergers, Acquisitions, and Partnerships, 2018
   • Overview of Regulatory Scenario – Key Countries
   • Key Industry Trends
   • Overview of e-Commerce Penetration – Key Countries

TOC Continued….

The global idiopathic inflammatory myopathy treatment market size is projected to reach USD 930.6 million by 2026, thereby exhibiting a CAGR of 4.6% during the forecast period. However, the market was worth USD 652.3 million in 2018. Fortune Business Insights™ published this information in an upcoming report, titled, “Idiopathic Inflammatory Myopathy Treatment Market Size, Share & Industry Analysis, By Disease Type (Dermatomyositis (DM), Polymyositis (PM), Inclusion Body Myositis (IBM), Necrotizing Autoimmune Myopathy (NAM), Others), By Treatment (Corticosteroids, Immunosuppressants, Intravenous Immunoglobulins, Others), By Route of Administration (Oral, Intravenous, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026.”

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/idiopathic-inflammatory-myopathy-treatment-market-100198

Fortune Business Insights™ profiles some of the most renowned companies present in the idiopathic inflammatory myopathy treatment market. They are as follows:

• Grifols, S.A.
• ImmunoForge
• Shire (Takeda Pharmaceutical Company Limited)
• ORPHAZYME A/S
• Mylan N.V.
• Biotest AG
• Pfizer Inc.
• CSL Limited (CSL Behring)
• LFB Group
• Kedrion S.p.A.
• Other key market players

Key Takeaways from the Report

• Quick outlook of the market entropy, such as new product launches, collaborations, deals, mergers and acquisitions, and agreements of key players.
• Elaborate information about the idiopathic inflammatory myopathy treatment market trends, growth aspect, complication, opportunities, and challenges.
• In-depth details of the performance of competitors.

Urgent Need for Modern Therapeutics to Boost Growth

Nowadays, numerous new, modern therapies are emerging across the world. The demand for more effective therapeutics is also rising day by day. Earlier, the traditional treatment options had limitations for the doses of immunosuppressants and glucocorticoids. They could be used up to a certain extent. However, today’s innovative therapeutic options help in treating a wide range of myositis.

Moreover, as more and more difficult-to-treat cases of idiopathic inflammatory myopathy increased, mankind realized the dire need for state-of-the-art therapies. It further created a high unmet demand for treatment options. It is expected to be one of the most crucial idiopathic inflammatory myopathy treatment market growth drivers.

The global pet insurance market size is projected to reach USD 11.25 billion by 2026. The increasing pet adoption in leading countries across the world will have a direct impact on the growth of the market. According to a report published by Fortune Business Insights, titled “Pet Insurance Market Size, Share & Industry Analysis, By Policy Coverage Type (Accident & Illness, Accident Only, Others), By Animal Type (Dog, Cat, Others), By Provider (Public, Private) and Regional Forecast, 2019-2026,” the market was worth USD 6.05 billion in 2018. Driven by flexibility in product offerings, the market will exhibit a CAGR of 8.0% during the forecast period, 2019-2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/pet-insurance-market-101956

A few of the leading companies that are operating in the global market include:

• Trupanion
• Anicom Holdings
• Nationwide Mutual Insurance Company
• ASPCA
• Healthy Paws Pet Insurance, LLC.
• Embrace Pet Insurance Agency, LLC
• Figo Pet Insurance LLC.
• Agria Pet Insurance Ltd
• 24PetWatch
• Pets Best Insurance Services, LLxC.

The pet insurance market will benefit from the increasing pet adoption in leading countries across the world. Pet insurance refers to a policy that covers medical as well as accidental factors that is associated with the pets. The emphasis on the well-being and health of pets, by private as well as government organizations will create several growth opportunities. The presence of several private organizations offering premium insurance policies will have a positive impact on the growth of the market in the forthcoming years. Several companies are focused on offering novel services as well as concessions in a bid to establishing a stronghold in the market. These factors will aid the growth of the market in the coming years.

Increasing Number of Company Mergers and Collaborations to Aid Market Growth

The report encompasses several factors that have contributed to the growth of the market in recent years. It highlights a few of the leading market drivers and analyzes their impact on the market. Among all factors, the increasing number of company mergers and collaborations have had a positive impact on market growth. In October 2019, Petplan, a leading pet insurance provider, announced that it has been acquired by Warnbug Pincus. Warnbug is a leading private equity firm that mainly focuses on growth-oriented investing. With this acquisition, the company will look to outperform its counterparts and in doing so, establish a strong presence in the market. The report highlights a few of the other company mergers that have graced the market in recent years and gauges their impact on the market.